{
    "pmcid": "11483107",
    "qa_pairs": {
        "How did the integration of AlphaFold-Multimer with HADDOCK improve complex modeling?": [
            "By using ensembles of antibody structures to enhance docking success rates",
            "By increasing the speed of model generation",
            "By reducing the computational cost of simulations",
            "By eliminating the need for any docking protocols"
        ],
        "What is a key implication of AlphaFold-Multimer's performance for SARS-CoV-2 nanobody design?": [
            "Its antigen models can be used in ensemble docking approaches to identify potential nanobody candidates",
            "It can independently predict high-accuracy nanobody binders without additional tools",
            "It provides direct experimental validation of nanobody efficacy",
            "It eliminates the need for any further computational analysis"
        ],
        "What is the primary focus of AlphaFold-Multimer as discussed in the paper?": [
            "Predicting protein-protein interactions, including antibody-antigen complexes",
            "Modeling small molecule interactions with proteins",
            "Simulating RNA folding and interactions",
            "Designing synthetic peptides for therapeutic use"
        ],
        "What was the success rate of AlphaFold-Multimer in predicting accurate antibody-antigen complex structures for Top1 ranked models?": [
            "0.22",
            "0.50",
            "0.75",
            "0.90"
        ],
        "Which region of the antibody structure did AlphaFold-Multimer and ABodyBuilder2 perform best in modeling?": [
            "CDR H3 region",
            "Fab region",
            "Fc region",
            "VL region"
        ]
    }
}